# Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

> **NCT05763199** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of California, Davis** · enrollment: 20 (estimated)

## Conditions studied

- Ovarian Epithelial Carcinoma
- Fallopian Tube Carcinoma
- Peritoneal Carcinoma

## Interventions

- **DIETARY_SUPPLEMENT:** AHCC
- **DRUG:** Chemotherapy
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05763199
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05763199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05763199, "Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT05763199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*